Co-precipitation of a therapeutic agent into hydroxyapatite coatings

Patent metadata

Field	Value
Publication number	US-9919077-B2
Application number	US-201414897352-A
Country	US
Kind code	B2
Filing date	Jun 19, 2014
Priority date	Jun 21, 2013
Publication date	Mar 20, 2018
Grant date	Mar 20, 2018

Abstract

A method for co-precipitating a therapeutic agent into a hydroxyapatite coated surface includes the steps of providing a surface and applying a hydroxyapatite seed layer on the surface. The hydroxyapatite seed layered surface is contacted with a solution including the therapeutic agent and a co-precipitated therapeutic agent, hydroxyapatite layer is formed on the coated surface to uniformly distribute the therapeutic agent in the layer. Further, an implant having sustained therapeutic agent delivery includes a base and an hydroxyapatite seed layer disposed on a surface of the base. A co-precipitated hydroxyapatite coating is disposed on the seed layer. The coating includes a therapeutic agent, wherein the therapeutic agent is provided in a solution of therapeutic agent.

First claim

What is claimed is:

1. A method for co-precipitating a therapeutic agent into a hydroxyapatite coated surface comprising the steps of:
providing a surface which includes a coating selected from the group of TiO 2 , TiO, TiCrO 2 , Ti 2 O 3 , Ti 3 O 5 , SiO 2 , MgO 2 , AlO 2 , MgO, Al 2 O 3 , and CrO 2 ;
applying a hydroxyapatite seed layer having a thickness of 0.1 μm to 1 μm on the surface;
contacting the hydroxyapatite seed layered surface with a solution including the therapeutic agent; and
forming a co-precipitated therapeutic agent, hydroxyapatite layer on the coated surface to uniformly distribute the therapeutic agent in the layer.

2. A method according to claim 1 , wherein the therapeutic agent is selected from the group of antibiotics, vitamins, chemotherapy drugs, bisphosphonates, strontium ranelate, PTH, osteoporotic drugs, growth factors, or a combination thereof.

3. A method according to claim 1 , wherein the surface is a material selected from the group of titanium, titanium alloy, nickel-titanium alloy, tantalum, platinum-iridium alloy, gold, magnesium, stainless steel, chromo-cobalt alloy, ceramics, biocompatible plastics or polymers and combinations thereof.

4. A method according to claim 1 , wherein the hydroxyapatite seed layer is grown biomimetically.

5. A method according to claim 1 , wherein the co-precipitated therapeutic agent, hydroxyapatite layer is grown biomimetically.

6. A method according to claim 1 , wherein the thickness of the co-precipitated layer is of 1 μm to 10 μm.

7. A method according to claim 1 , wherein the therapeutic agent in the solution including the therapeutic agent has a concentration of 0.5 to 40 mg/ml.

8. A method according to claim 1 , wherein the co-precipitated therapeutic agent, hydroxyapatite layer and the seed layer are ion substituted hydroxyapatite.

9. A method according to claim 8 , wherein the substitution ions are bone mineral relevant ions.

10. A method according to claim 8 , wherein the substitution ions are selected from the group of Si, Sr, Mg, C02-3, and F ions.

11. A method according to claim 1 , wherein the solution including the therapeutic agent is heated to a temperature of about 30° C. to about 90° C.

12. A method according to claim 11 , wherein the temperature is 60° C.

13. A method according to claim 1 , wherein the seed layer is applied by soaking the surface in phosphate buffered saline solution containing calcium and phosphate ions.

14. A method according to claim 13 , wherein the phosphate buffered saline solution has a temperature of from 30 to 90° C.

15. A method according to claim 14 , wherein the phosphate buffered saline solution has a temperature of 60° C.

16. A hydroxyapatite coated surface co-precipitated with a therapeutic agent according to the method of claim 1 .

17. A device having a hydroxyapatite coated surface co-precipitated with a therapeutic agent according to the method of claim 1 .

18. The device of claim 17 , wherein the device is selected from the group of implants, pins, fixation pins, orthopedic devices, dental implants, stents, drug delivery devices, sheets, films, meshes, soft tissue implants, implantable electrodes, implantable sensors, drug delivery pumps, tissue barriers and shunts.

Assignees

• Stryker European Holdings I Llc

Inventors

• Lilja Mirjam
• Procter Philip
• Steckel Hartwig
• Sörensen Torben Christian
• Soerensen Jan

Classifications

• A61L31/086

  Phosphorus-containing materials, e.g. apatite · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title

• A61L31/16

  Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

• A61L27/54

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

• A61L27/32 Primary

  Phosphorus-containing materials, e.g. apatite · CPC title